Trigeminal neuralgia: when the drugs stop working

For a while, the tablet worked. The lightning-bolt jolts through your cheek or jaw settled down, and life became livable again. Then the dose crept up, or the pain broke through anyway, or the drowsiness and unsteadiness became their own kind of prison. If you are reading this, you have probably reached the question that brings most people to look into trigeminal neuralgia treatment in Japan: what happens when the medication stops being enough? Here is the reassuring part to start with — trigeminal neuralgia is not life-threatening, and when drugs fail there are genuine, well-established procedures that can substantially relieve the pain in many people, one of which treats the actual cause rather than just muffling it.

What trigeminal neuralgia is

Trigeminal neuralgia is sudden, severe, electric-shock-like facial pain in the territory of the trigeminal nerve — usually the cheek, jaw, or around the eye, almost always on one side. The attacks are brief but intense, and they are often set off by ordinary things: chewing, brushing your teeth, washing your face, a breath of cold air, even talking. In the most common ("classical") form, the culprit is a blood vessel pressing on the trigeminal nerve where it leaves the brainstem, which over time wears down the nerve's insulation. That single fact is why one of the treatments can be a genuine fix rather than a patch. It is also a genuinely treatable pain — many people respond well to the right procedure — which is worth holding onto if you are reading this at 3 a.m.

Symptoms — what the pain is like

The hallmark of classical trigeminal neuralgia is very specific, and recognizing it matters, because the pattern itself guides the diagnosis:

• Electric, stabbing, shock-like pain — not a dull ache, but sharp jolts.
• Brief attacks — each spasm lasts seconds to a couple of minutes, often in clusters, then eases.
• One side of the face — usually the cheek and jaw (the second and third divisions of the nerve), less often around the eye.
• Triggered by light touch — chewing, talking, brushing teeth, shaving, a cold wind. Many people find "trigger zones" they learn to protect.
• Pain-free gaps — between attacks there is often no pain at all, though the illness can come in bouts lasting weeks or months, with remissions in between.

Most people with this exact picture have classical trigeminal neuralgia. But some features point away from the classical form and toward a different, "secondary" cause that deserves looking into — for example a constant background ache rather than clean jolts, numbness or weakness of the face, both sides being affected, or onset at a young age. Those are not emergencies, but they change what should happen next; we come back to them in "When to have it looked at more closely," below.

Causes and risk factors

Trigeminal neuralgia is usually sorted into three groups, and which group you are in shapes the whole plan:

• Classical — by far the most common. A blood vessel (usually an artery, sometimes a vein) presses on the trigeminal nerve near the brainstem and, over years, frays its insulating sheath. This is the form MVD is designed to treat.
• Secondary — the same pain, but caused by an identifiable condition pressing on or damaging the nerve. The usual examples are a benign tumor near the nerve (such as a meningioma) or multiple sclerosis, in which demyelination inside the brainstem produces the pain. Overall, an identifiable structural cause is found in about 15% of cases, which is one of the main reasons an MRI matters.
• Idiopathic — the pain is typical but no clear vessel conflict or other cause is found.

Unlike some conditions we cover, trigeminal neuralgia is not mainly driven by lifestyle — there is no smoking-and-blood-pressure story to act on here. The background factors are largely ones you cannot change: it is more common with age (most often after 50), somewhat more common in women, and clearly associated with multiple sclerosis — which is why MS is actively considered when the pain starts young or affects both sides. None of these causes the pain on its own; they simply shift who tends to get it.

Tests and diagnosis — what each one shows

Trigeminal neuralgia is, first and foremost, a clinical diagnosis: there is no blood test, and the story of the pain — its shock-like quality, its triggers, its one-sidedness — does most of the work. But imaging has a real and specific job.

• MRI of the brain — the central test, and it does two things at once. It looks for a vessel pressing on the nerve, which supports the classical diagnosis and helps plan MVD; and, just as importantly, it checks for a secondary cause — a tumor or the demyelination of multiple sclerosis. A dedicated high-resolution sequence is often used to see the fine anatomy where the nerve meets the vessels.
• MRA (MR angiography) — often added within the same MRI session to map the arteries around the nerve in more detail before surgery.

One honest caveat: even a good MRI cannot always prove that a vessel it shows is the true cause — a touching vessel is common and not always guilty — so the pictures are read together with your symptoms, never in isolation. In Japan MRI is widely and quickly available, which makes this workup straightforward. Your doctor chooses the sequences, and reads them, in light of your particular picture.

First, the medication — and why it can stop being enough

The first-line treatment everywhere is medication, and in Japan the mainstay is carbamazepine. (A close relative, oxcarbazepine, is used abroad, but it is not approved for trigeminal neuralgia in Japan.) For many people carbamazepine is strikingly effective at first: initial pain relief is often quoted at around 70–90%, which is why a good response is itself part of how the diagnosis is confirmed. But two things commonly happen over the years. The drug can gradually lose its grip, so attacks break through despite higher doses; and the side effects — drowsiness, dizziness, unsteadiness, low sodium, and skin reactions, rarely a serious one — can become as disabling as the pain itself. If a rash appears, it is important not to keep taking the drug on your own judgment but to be seen promptly. When either the effect fades or the side effects become intolerable, international guidelines (including the European Academy of Neurology's) suggest it is time to talk about a procedure, rather than simply stacking on more medication. Reaching that point is not a failure on your part; it is a recognized stage of the illness.

How Japan approaches it: the role of MVD

When the conversation turns to procedures, the option Japan is particularly associated with is microvascular decompression (MVD). It is open microsurgery: through a small opening behind the ear, the surgeon finds the offending vessel, lifts it off the trigeminal nerve, and places a soft cushion between them. Because it removes the underlying cause, MVD offers the most durable relief of any option. The landmark long-term study — Barker, Jannetta and colleagues, published in the New England Journal of Medicine in 1996 — followed more than 1,100 patients and found that about 70% were still free of pain a decade after surgery, without medication, with most recurrences happening within the first couple of years.

Why is MVD associated with Japan? Partly volume and tradition: Japanese neurosurgery has deep experience with this operation and with the intricate, variable vascular anatomy around the nerve, and it is offered at many centers. That said, "Japan is good at MVD" is not a reason to choose surgery — the reason is whether MVD is right for your situation. It is best suited to classical trigeminal neuralgia with a clear vessel–nerve conflict on MRI, in a patient well enough for general anesthesia. Like any brain surgery it carries real, if uncommon, risks — including hearing changes, facial numbness, the general risks of anesthesia, and — more rarely — a cerebrospinal fluid leak or, very rarely, a more serious complication — which belong in an honest conversation before any decision.

The other procedures, honestly compared

MVD is not the only route, and it is not right for everyone. The main alternatives:

• Gamma knife (stereotactic radiosurgery) — focused radiation aimed at the nerve, with no incision and no general anesthesia. It is attractive for people who cannot or prefer not to have open surgery. The trade-offs: relief is usually delayed by weeks to months rather than immediate, it may be less durable than MVD, and facial numbness can develop over time.
• Percutaneous procedures — a needle is passed through the cheek to the nerve to injure it deliberately (by heat, balloon compression, or a chemical). These are less invasive and can be done in frailer or older patients, and relief is often quick. The trade-offs: numbness is common — and, rarely, of a different quality, such as painful numbness in the numb area (anesthesia dolorosa) or reduced sensation of the cornea — and recurrence rates are higher than with MVD.

None of these is simply "better." Open surgery buys durability at the cost of invasiveness; the less-invasive options trade some durability and more numbness for a gentler procedure. The right fit depends on your MRI findings, your age and general health, how much numbness you could accept, and how you weigh a bigger operation now against the chance of the pain returning later.

When the pain comes back: thinking about a second operation

Sometimes the pain returns after a procedure that first worked well — and this deserves its own calm section, because it is where a lot of fear and misinformation live. Recurrence is a known part of the picture; it does not mean nothing more can be done. The first step is to understand why it came back. Fresh imaging can look for a vessel that was not the whole story the first time, or a different vessel that has since come to rest against the nerve. In the recurrent setting the offending vessel can occasionally be a different one from the original — something I have reported as a single case observation in the neurosurgical literature — which is one reason a careful, unhurried re-assessment matters rather than assuming the first operation simply "failed." A considered second MVD is a recognized option in the right hands; so are gamma knife and percutaneous procedures. The point is that recurrence reopens the same menu of choices, and the decision is made again, together with a surgeon, on the specifics of your case.

Outlook and follow-up

"What happens from here" depends on which path you are on. In general terms:

• On medication — many people are well controlled for years. The realistic expectation is not "cured forever" but "managed," and for a meaningful number the drug slowly loses its hold or the side effects mount, which is what brings the procedure conversation forward.
• After MVD — this offers the most durable result: in the long-term data, roughly 70% remained pain-free about ten years later without medication. When recurrence happens it is most often in the first couple of years, which is why the early follow-up period matters.
• After gamma knife or a percutaneous procedure — relief is real but, on average, less durable, with more recurrences over the following years and a higher chance of lasting facial numbness. For many older or frailer patients that trade is entirely reasonable.

All of those percentages come from following large groups of patients; none of them was written about you. How your own story unfolds depends on the cause of your pain, the procedure chosen, and your health — and the doctor following you is the right judge of that.

Living with trigeminal neuralgia

Between attacks, and while treatment is being sorted out, day-to-day life is often dominated by avoiding triggers — and that avoidance can quietly do its own harm. A few things worth attention:

• Eating and weight — when chewing sets off the pain, people cut back on food, and unintended weight loss is common. Softer foods, or timing meals to your medication, can help you keep eating properly.
• Mouth care — fear of brushing can lead to neglected teeth, which brings its own dental pain. A soft brush and gentle technique matter more than usual here.
• Cold air — a scarf over the cheek in cold or windy weather heads off a common trigger.
• Mood — recurring, unpredictable pain wears people down, and anxiety or low mood are common companions. This is worth raising with your doctor, not enduring silently.

The overall aim is to keep the pain from dictating the shape of your days. Exactly how to manage your own routine, work, and activities is worth working out with the doctor who knows your case.

When to have it looked at more closely

First, the reassurance: trigeminal neuralgia itself is not dangerous to your life, and this is not a section about calling an ambulance. It is about a different thing — not staying on painkillers indefinitely when the pattern hints that something else is driving the pain. Arrange to be seen (an ordinary appointment, and usually an MRI) rather than simply continuing medication if any of these apply:

• the pain started before about age 40
• the pain affects both sides of the face
• there is a constant, dull background ache, not just the clean electric jolts
• you notice numbness or reduced sensation on the face, or weakness of the facial muscles
• there is hearing loss, ringing in the ear, or other new neurological symptoms on that side

These features do not mean something dreadful is certain — but they are the recognized signs of a possible secondary cause (such as a tumor or multiple sclerosis), and the sensible response is a proper look with imaging rather than an ever-rising drug dose. Separately, and as with any condition: if you ever have a sudden, severe, unfamiliar headache or other acute neurological symptoms, that is a general medical emergency and you should seek urgent care.

Questions worth taking back to your doctor

Frequently asked questions

What does trigeminal neuralgia feel like, and could my facial pain be something else?

Classical trigeminal neuralgia is sudden, brief, electric-shock-like pain on one side of the face, set off by light touch — chewing, brushing teeth, a cold breeze. Most cases are that classical picture. But some features point away from it and toward a secondary cause worth investigating: pain that starts before about age 40, pain on both sides, a constant dull ache rather than jolts, or numbness, facial weakness, or hearing loss alongside the pain. These do not mean an emergency, but they are a reason to be seen and have an MRI rather than simply staying on painkillers.

My carbamazepine has stopped working. Does that mean I need surgery?

Not automatically, but it is the usual trigger for the conversation. When carbamazepine or oxcarbazepine no longer controls the pain, or the side effects have become intolerable, guidelines suggest discussing a procedure rather than simply piling on more drugs. Which procedure — and whether now is the right time — depends on your MRI, your age and health, and your own priorities, and is decided with your doctor.

What tests are used to diagnose trigeminal neuralgia?

The diagnosis is made mainly from the story of the pain — there is no blood test for it. The key scan is MRI, which does two jobs: it looks for a blood vessel pressing on the trigeminal nerve (which supports the classical diagnosis and helps plan MVD), and, just as importantly, it checks for a secondary cause such as a tumor or multiple sclerosis. In Japan MRI is widely available, and a dedicated high-resolution sequence is often used to see the nerve and nearby vessels in detail.

What is microvascular decompression, and why is it associated with Japan?

Microvascular decompression (MVD) is open microsurgery that lifts a blood vessel off the trigeminal nerve and cushions it, treating the usual cause of classical trigeminal neuralgia rather than just deadening the nerve. In a large long-term study, about 70% of patients were still free of pain a decade later, without medication. Japan has deep experience in MVD and in the detailed vascular anatomy around the nerve, which is one reason patients look to Japanese centers for it.

What is the difference between MVD, gamma knife, and percutaneous procedures?

MVD is open surgery under general anesthesia that addresses the cause and offers the most durable pain relief, but it is the most invasive. Gamma knife is focused radiation with no incision; relief is often delayed by weeks to months and may be less durable. Percutaneous procedures reach the nerve through the cheek to injure it deliberately; they are less invasive and useful for frailer patients, but numbness and recurrence are more common. The best fit depends on your health, MRI findings, and preferences.

The pain came back after my first operation. What are my options?

Recurrence after an initially successful MVD does happen, and it is not the end of the road. Repeat imaging can look for a vessel that was missed or a new one now touching the nerve, and a carefully considered second operation is a recognized option; so are gamma knife and percutaneous procedures. The right path depends on why the pain returned, so a fresh, unhurried assessment matters.

Can I discuss my trigeminal neuralgia with a Japanese neurosurgeon online?

Yes. Japan Medical Bridge provides one-on-one video consultations in English with a Japanese neurosurgeon, covering how facial-pain cases of this kind are generally approached in Japan. Nothing in the session is a diagnosis or medical advice, and what to actually do about your pain remains a decision for you and your own doctor.